Case Activity (1661)

1. Order | Filed: July 10, 2026 | Entered: July 10, 2026 IPSEN BIOPHARMACEUTICALS, INC. et al v. CONJUPRO BIOTHERAPEUTICS, INC. et al

   Patent - Abbreviated New Drug Application(ANDA) | New Jersey

   Order on Motion to Seal Document

   FINDINGS OF FACT AND CONCLUSIONS OF LAW AND ORDER GRANTING 174 MOTION TO SEAL. Signed by Magistrate Judge Matthew J. Skahill on 7/10/2026. (adc, )

2. Order | Filed: July 10, 2026 | Entered: July 10, 2026 IPSEN BIOPHARMACEUTICALS, INC. et al v. CONJUPRO BIOTHERAPEUTICS, INC. et al

   Patent - Abbreviated New Drug Application(ANDA) | New Jersey

   Order

   Text Order: Having reviewed counsel's letter [ECF No. 226], and it appearing that the discovery dispute raised in ECF Nos. 181, 184, and 186 remains active but that it may be moot depending on Defendants' noninfringement positions in their forthcoming August 3, 2026 rebuttal expert reports, it is ORDERED that the August 6, 2026 conference is moved to August 20, 2026 at 10:30 a.m. so that counsel may produce and review the reports and then strive to resolve this issue. A joint status letter is due to the Court on this issue on August 13, 2026. The call-in number for the August 20, 2026 telephone conference at 10:30 a.m. is 856-210-8988, access code 730 681 177#. So Ordered by Magistrate Judge Matthew J. Skahill on 7/10/26. (Shaw, Alexis)

3. 1659 additional result(s)